A citation-based method for searching scientific literature

Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer, Roman Jaeschke, David Rind, Joerg Meerpohl, Philipp Dahm, Holger J Schünemann. J Clin Epidemiol 2011
Times Cited: 3504







List of co-cited articles
130 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
19

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
17

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
13

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
11

GRADE guidelines: 3. Rating the quality of evidence.
Howard Balshem, Mark Helfand, Holger J Schünemann, Andrew D Oxman, Regina Kunz, Jan Brozek, Gunn E Vist, Yngve Falck-Ytter, Joerg Meerpohl, Susan Norris,[...]. J Clin Epidemiol 2011
11

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
11

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
10

RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
9

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
9

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
8

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
8

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
8

GRADE guidelines 6. Rating the quality of evidence--imprecision.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, David Rind, P J Devereaux, Victor M Montori, Bo Freyschuss, Gunn Vist,[...]. J Clin Epidemiol 2011
7

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
7

Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
6

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).
Gordon H Guyatt, Andrew D Oxman, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Victor Montori, Elie A Akl, Ben Djulbegovic, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2011
6

GRADE guidelines: 2. Framing the question and deciding on important outcomes.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, David Atkins, Jan Brozek, Gunn Vist, Philip Alderson, Paul Glasziou, Yngve Falck-Ytter, Holger J Schünemann. J Clin Epidemiol 2011
896
6

GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
Pablo Alonso-Coello, Holger J Schünemann, Jenny Moberg, Romina Brignardello-Petersen, Elie A Akl, Marina Davoli, Shaun Treweek, Reem A Mustafa, Gabriel Rada, Sarah Rosenbaum,[...]. BMJ 2016
349
6

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
6

GRADE guidelines: 9. Rating up the quality of evidence.
Gordon H Guyatt, Andrew D Oxman, Shahnaz Sultan, Paul Glasziou, Elie A Akl, Pablo Alonso-Coello, David Atkins, Regina Kunz, Jan Brozek, Victor Montori,[...]. J Clin Epidemiol 2011
640
5

GRADE guidelines: 7. Rating the quality of evidence--inconsistency.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Paul Glasziou, Roman Jaeschke, Elie A Akl,[...]. J Clin Epidemiol 2011
5

GRADE guidelines: 5. Rating the quality of evidence--publication bias.
Gordon H Guyatt, Andrew D Oxman, Victor Montori, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Ben Djulbegovic, David Atkins, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2011
855
5

GRADE guidelines: 8. Rating the quality of evidence--indirectness.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Yngve Falck-Ytter, Roman Jaeschke, Gunn Vist,[...]. J Clin Epidemiol 2011
828
5

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
5

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Brian Hutton, Georgia Salanti, Deborah M Caldwell, Anna Chaimani, Christopher H Schmid, Chris Cameron, John P A Ioannidis, Sharon Straus, Kristian Thorlund, Jeroen P Jansen,[...]. Ann Intern Med 2015
5

GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health.
Holger J Schünemann, Reem Mustafa, Jan Brozek, Nancy Santesso, Pablo Alonso-Coello, Gordon Guyatt, Rob Scholten, Miranda Langendam, Mariska M Leeflang, Elie A Akl,[...]. J Clin Epidemiol 2016
143
4

Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
Miranda Cumpston, Tianjing Li, Matthew J Page, Jacqueline Chandler, Vivian A Welch, Julian Pt Higgins, James Thomas. Cochrane Database Syst Rev 2019
919
4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
4

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
4


GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations.
Jeff Andrews, Gordon Guyatt, Andrew D Oxman, Phil Alderson, Philipp Dahm, Yngve Falck-Ytter, Mona Nasser, Joerg Meerpohl, Piet N Post, Regina Kunz,[...]. J Clin Epidemiol 2013
623
4

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
4

GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.
Holger J Schünemann, Wojtek Wiercioch, Jan Brozek, Itziar Etxeandia-Ikobaltzeta, Reem A Mustafa, Veena Manja, Romina Brignardello-Petersen, Ignacio Neumann, Maicon Falavigna, Waleed Alhazzani,[...]. J Clin Epidemiol 2017
167
4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
4

GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes.
Gordon H Guyatt, Kristian Thorlund, Andrew D Oxman, Stephen D Walter, Donald Patrick, Toshi A Furukawa, Bradley C Johnston, Paul Karanicolas, Elie A Akl, Gunn Vist,[...]. J Clin Epidemiol 2013
288
3

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.
Gordon Guyatt, Andrew D Oxman, Shahnaz Sultan, Jan Brozek, Paul Glasziou, Pablo Alonso-Coello, David Atkins, Regina Kunz, Victor Montori, Roman Jaeschke,[...]. J Clin Epidemiol 2013
360
3

What is "quality of evidence" and why is it important to clinicians?
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Gunn E Vist, Yngve Falck-Ytter, Holger J Schünemann. BMJ 2008
3

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.
David Atkins, Martin Eccles, Signe Flottorp, Gordon H Guyatt, David Henry, Suzanne Hill, Alessandro Liberati, Dianne O'Connell, Andrew D Oxman, Bob Phillips,[...]. BMC Health Serv Res 2004
590
3

Grading quality of evidence and strength of recommendations.
David Atkins, Dana Best, Peter A Briss, Martin Eccles, Yngve Falck-Ytter, Signe Flottorp, Gordon H Guyatt, Robin T Harbour, Margaret C Haugh, David Henry,[...]. BMJ 2004
3

The GRADE Working Group clarifies the construct of certainty of evidence.
Monica Hultcrantz, David Rind, Elie A Akl, Shaun Treweek, Reem A Mustafa, Alfonso Iorio, Brian S Alper, Joerg J Meerpohl, M Hassan Murad, Mohammed T Ansari,[...]. J Clin Epidemiol 2017
170
3


QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.
Penny F Whiting, Anne W S Rutjes, Marie E Westwood, Susan Mallett, Jonathan J Deeks, Johannes B Reitsma, Mariska M G Leeflang, Jonathan A C Sterne, Patrick M M Bossuyt. Ann Intern Med 2011
3

PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement.
Jessie McGowan, Margaret Sampson, Douglas M Salzwedel, Elise Cogo, Vicki Foerster, Carol Lefebvre. J Clin Epidemiol 2016
885
3

Guidelines International Network: toward international standards for clinical practice guidelines.
Amir Qaseem, Frode Forland, Fergus Macbeth, Günter Ollenschläger, Sue Phillips, Philip van der Wees. Ann Intern Med 2012
424
3

Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines.
Holger J Schünemann, Lubna A Al-Ansary, Frode Forland, Sonja Kersten, Jorma Komulainen, Ina B Kopp, Fergus Macbeth, Susan M Phillips, Craig Robbins, Philip van der Wees,[...]. Ann Intern Med 2015
119
3


A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.
Milo A Puhan, Holger J Schünemann, Mohammad Hassan Murad, Tianjing Li, Romina Brignardello-Petersen, Jasvinder A Singh, Alfons G Kessels, Gordon H Guyatt. BMJ 2014
676
3

Utilization of the PICO framework to improve searching PubMed for clinical questions.
Connie Schardt, Martha B Adams, Thomas Owens, Sheri Keitz, Paul Fontelo. BMC Med Inform Decis Mak 2007
718
3

AGREE II: advancing guideline development, reporting and evaluation in health care.
Melissa C Brouwers, Michelle E Kho, George P Browman, Jako S Burgers, Francoise Cluzeau, Gene Feder, Béatrice Fervers, Ian D Graham, Jeremy Grimshaw, Steven E Hanna,[...]. CMAJ 2010
3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.